化学生物学对STING激动剂作为瘤免疫治疗的观点
1Department of Pharmacology, China Pharmaceutical University, No 24, TongJiaXiang, Gulou District, Nanjing, 210009, P. R. China.
ChemMedChem
|October 5, 2023
概括
干扰素基因刺激剂 (STING) 激素激活先天免疫力,将冷瘤转化为热瘤,增强T细胞反应,产生强效,长期的抗瘤作用. 这种突破性的免疫疗法方法在癌症治疗中显示出巨大的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药用化学 医学化学
背景情况:
- 干扰素基因刺激器 (STING) 是先天免疫的关键适应蛋白.
- 刺激激活促进I型干扰素分泌和T细胞介导的适应性免疫.
- 这种免疫激活将免疫冷瘤转化为热瘤,增强T细胞招募和抗瘤效应.
研究的目的:
- 审查STING信号通路与瘤免疫之间的相关性.
- 探索STING激活对其他生物过程的影响.
- 总结用于癌症治疗的STING激动剂的开发和药物化学.
主要方法:
- 文献综述侧重于STING通路,瘤免疫力和STING激动剂.
- 从药物化学的角度分析STING激动剂的发展.
- 评估STING激动剂在癌症中的治疗潜力和挑战.
主要成果:
- 刺痛激动剂代表了一种新型的先天性免疫激动剂类别,其潜力超出了传统的免疫检查点抑制剂.
- 激活STING有效地增强T细胞介导的抗瘤免疫力.
- 刺痛激动剂在治疗各种癌症群体方面显示出显著的前景.
结论:
- 刺痛激动剂是癌症免疫治疗的突破性治疗策略.
- 从药物化学的角度来看,进一步开发和优化至关重要.
- 尽管面临挑战,STING激动剂仍有可能成为各种癌症的热门治疗方法.
相关概念视频
Tumor Immunotherapy
544
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
544
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cytotoxic T Cells-mediated Immune Response
955
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
955
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
389
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
389


